Nifedipine plus candesartan combination increases blood pressure control regardless of race and improves the side effect profile: DISTINCT randomized trial results. - Wikidata - wikimedia - TriplyDB

Nifedipine plus candesartan combination increases blood pressure control regardless of race and improves the side effect profile: DISTINCT randomized trial results.

Nifedipine plus candesartan combination increases blood pressure control regardless of race and improves the side effect profile: DISTINCT randomized trial results.

http://www.wikidata.org/entity/Q34488929

about

Combination therapy with nifedipine GITS 60 mg: subanalysis of a prospective, 12-week observational study (AdADOSE)Nifedipine GITS/Candesartan Combination Therapy Lowers Blood Pressure Across Different Baseline Systolic and Diastolic Blood Pressure Categories: DISTINCT Study Subanalyses Blood pressure-lowering effects of nifedipine/candesartan combinations in high-risk individuals: subgroup analysis of the DISTINCT randomised trial.Follow-up of Antihypertensive Therapy Improves Blood Pressure Control: Results of HYT (HYperTension survey) Follow-up.Fixed-dose combination of nifedipine gastrointestinal therapeutic system and candesartan cilexetil in patients with moderate-to-severe essential hypertension: an open-label, long-term safety and efficacy study.

P2860

Q36482346-ABFC0F70-9ADF-4261-A55F-24FD83F909B0 Q37418077-12F80C9D-E797-444E-AE0F-F16D9BEDA7DA Q37634845-79154795-6F67-46B1-A2F2-BD1AD0292D58 Q50653470-3DB32B56-9C44-442A-A412-3947A9FAE779 Q52846002-9181435F-D0B8-49AB-B8D9-EC53E901490F

P2860

Nifedipine plus candesartan combination increases blood pressure control regardless of race and improves the side effect profile: DISTINCT randomized trial results.

http://www.wikidata.org/entity/Q34488929

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Nifedipine plus candesartan co ...... INCT randomized trial results.

@ast

Nifedipine plus candesartan co ...... INCT randomized trial results.

@en

Nifedipine plus candesartan co ...... INCT randomized trial results.

@nl

type

label

Nifedipine plus candesartan co ...... INCT randomized trial results.

@ast

Nifedipine plus candesartan co ...... INCT randomized trial results.

@en

Nifedipine plus candesartan co ...... INCT randomized trial results.

@nl

prefLabel

Nifedipine plus candesartan co ...... INCT randomized trial results.

@ast

Nifedipine plus candesartan co ...... INCT randomized trial results.

@en

Nifedipine plus candesartan co ...... INCT randomized trial results.

@nl

P1433

Q34488929-80F5A98D-6EF2-4ABD-814E-B429E6B12B78

P1476

Q34488929-C5261FD2-EAFC-4666-86C7-6BB81C5D0AA0

P2093

Q34488929-1294B46A-C9F6-4087-B9B1-B96757215EFC

Q34488929-30D7CDBA-7B85-432F-8388-D64E07FF521C

Q34488929-33789BDE-59F8-48C6-A178-418F02F7CC00

Q34488929-3E0E2229-CDD2-48C7-A5A9-B8246E06EF1B

Q34488929-4658F906-A1F0-449F-BFF9-9A25E8E8530F

Q34488929-4E50DDE1-C88F-4387-B329-EEFA809B3D8C

Q34488929-8674B2A6-7081-4853-BC0A-BD8FB9C585CF

Q34488929-B41B888F-5A8D-4F40-92B0-6733F3AD02C8

P2860

Q34488929-0A213023-CF69-41DD-B045-BA73D9F7DC59

Q34488929-0BD6B9F9-EC69-4329-B73F-A68264C02187

Q34488929-0E27B63C-07A3-43F8-BF74-D12949342F48

Q34488929-0F14CD72-1B0D-426F-B3D0-85ABED1A5F56

Q34488929-172C8BCD-CB97-4015-A013-070D9CE955E7

Q34488929-187C0159-2B02-4D98-8C10-5A0B63BA5D10

Q34488929-1CCF348B-E581-418C-B28C-171073B79AB5

Q34488929-1D6302DE-862B-402E-A8BA-244800DA5CB2

Q34488929-339A9E83-9AC9-4AA3-A128-20B765D32BE9

Q34488929-3A607F4F-4370-460B-8567-242F8726918D

P304

Q34488929-921DAE1A-A60B-4A92-B474-06A289EB6C95

P31

Q34488929-29372AA5-71CD-419C-A85D-420C05D6A2A8

P356

Q34488929-98711C14-C48C-41AE-AF16-CDFB4F4AD329

P433

Q34488929-27590EDC-1307-46E7-BAF7-52FF0FECD688

P478

Q34488929-8BCF28F8-741A-4F60-8A8F-5A7E962A24F8

P50

Q34488929-3DE04005-4158-4812-B938-EF70022F71F3

Q34488929-6DA9E255-698A-4FB1-86E3-1DD462983D1E

Q34488929-F081BEEE-DC50-4C0F-A6DE-435149B64BD7

P577

Q34488929-E2BD2959-94E8-461D-836D-23C97790ABD2

P698

Q34488929-8E85F48E-D9D2-496B-8D80-029A45196F3D

P932

Q34488929-52388A9B-5C76-4E9D-A996-7544A82CB6C1

P356

HJH.0000000000000331

P1433

Journal of Hypertension

P1476

Nifedipine plus candesartan co ...... INCT randomized trial results.

@en

P2093

Andrew J Lewin

http://www.w3.org/2001/XMLSchema#string

Blas Gil-Extremera

http://www.w3.org/2001/XMLSchema#string

DISTINCT Investigators

http://www.w3.org/2001/XMLSchema#string

Domenic Sica

http://www.w3.org/2001/XMLSchema#string

Frank Heyvaert

http://www.w3.org/2001/XMLSchema#string

Giuseppe Villa

http://www.w3.org/2001/XMLSchema#string

Gloria Cha

http://www.w3.org/2001/XMLSchema#string

Peter Harvey

http://www.w3.org/2001/XMLSchema#string

P2860

Telmisartan, ramipril, or both in patients at high risk for vascular events.

Effects of losartan vs candesartan in reducing cardiovascular events in the primary treatment of hypertension

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial.

Efficacy and tolerability of amlodipine plus olmesartan medoxomil in patients with difficult-to-treat hypertension

2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension.

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.

Clinical pharmacokinetics of candesartan.

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

The use of combination drug therapy in the treatment of hypertension.

P304

2488-98; discussion 2498

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/HJH.0000000000000331

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

Giuseppe Mancia

Sverre E. Kjeldsen

P577

2014-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25144296

http://www.w3.org/2001/XMLSchema#string

P932

4227617

http://www.w3.org/2001/XMLSchema#string